Insider Transactions in Q4 2024 at Galectin Therapeutics Inc (GALT)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 24
2024
|
Richard A. Zordani Jr. |
BUY
Open market or private purchase
|
Direct |
10,000
+19.2%
|
$0
$0.82 P/Share
|
|
Dec 24
2024
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Direct |
10,000
+18.26%
|
$0
$0.81 P/Share
|
|
Dec 24
2024
|
Kary Eldred |
BUY
Open market or private purchase
|
Direct |
13,469
+17.46%
|
$0
$0.82 P/Share
|
|
Dec 23
2024
|
Khurram Jamil Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
13,654
-34.14%
|
$0
$0.88 P/Share
|
|
Dec 23
2024
|
Khurram Jamil Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+50.0%
|
-
|
|
Dec 23
2024
|
Jack W Callicutt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
40,000
-84.01%
|
$0
$0.89 P/Share
|
|
Dec 23
2024
|
Jack W Callicutt Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+45.65%
|
-
|
|
Dec 23
2024
|
Joel Lewis President and CEO |
SELL
Open market or private sale
|
Direct |
56,000
-5.88%
|
$0
$0.89 P/Share
|
|
Dec 23
2024
|
Joel Lewis President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
56,000
+5.55%
|
-
|
|
Oct 23
2024
|
Kary Eldred |
BUY
Open market or private purchase
|
Direct |
500
+0.99%
|
$1,000
$2.6 P/Share
|
|
Oct 17
2024
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Direct |
1,300
+3.6%
|
$2,600
$2.64 P/Share
|
|
Oct 16
2024
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
5,000
+5.88%
|
$10,000
$2.7 P/Share
|
|
Oct 16
2024
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Direct |
5,000
+13.0%
|
$10,000
$2.7 P/Share
|